Jan Sandström has a long career and extensive experience from the pharmaceutical industry as Business Developer and Board Member including Astrazeneca, PledPharma and TikoMed. He holds a M.Sc. in Pharmaceutical Sciences and a degree in Business Administration, and has previously participated in the development of the Swedish Shareholders’ Association as its Board Member.